Antimicrobial Peptides Market

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Antimicrobial Peptides Market contains market size and forecasts of Antimicrobial Peptides in global, including the following market information:

Global Antimicrobial Peptides Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Antimicrobial Peptides Market Sales, 2017-2022, 2023-2028, (Mg)

Global top five Antimicrobial Peptides companies in 2021 (%)

The global Antimicrobial Peptides market was valued at 5 million in 2021 and is projected to reach US$ 7 million by 2028, at a CAGR of 5.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Plant Antimicrobial Peptides Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antimicrobial Peptides include AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech and Sunsmile, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Antimicrobial Peptides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antimicrobial Peptides Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Mg)

Global Antimicrobial Peptides Market Segment Percentages, by Type, 2021 (%)

Plant Antimicrobial Peptides

Microbial Antimicrobial Peptides

Animal Antimicrobial Peptides

Global Antimicrobial Peptides Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Mg)

Global Antimicrobial Peptides Market Segment Percentages, by Application, 2021 (%)

Pharmaceuticals

Feed Additives

Others

Global Antimicrobial Peptides Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Mg)

Global Antimicrobial Peptides Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antimicrobial Peptides revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Antimicrobial Peptides revenues share in global market, 2021 (%)

Key companies Antimicrobial Peptides sales in global market, 2017-2022 (Estimated), (Mg)

Key companies Antimicrobial Peptides sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AnaSpec

AMP Biotech

Phoenix Biotech

Novabiotics

Chinese Peptide

Ontores

GenScript

Hycult Biotech

Sunsmile

Ruixing Biotechnology

Zhongnong Yingtai Biotechnology

Glam Technology

ProteLight Pharmaceutical & Biotechnology